Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by HUIYING ZENG
Efficacy and Adverse Events of Transcatheter Arterial Chemoembolization in Combination With Sorafenib in the Treatment of Unresectable Hepatocellular Carcinoma
Molecular and Clinical Oncology
Cancer Research
Oncology
Related publications
Safety and Efficacy of Transcatheter Arterial Chemoembolization With Embospheres in Treatment of Hepatocellular Carcinoma
Journal of Digestive Diseases
Gastroenterology
Multimodality Treatment With Conventional Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma
Digestion
Gastroenterology
Safety and Efficacy of Transcatheter Arterial Chemoembolization Plus Radiotherapy Combined With Sorafenib in Hepatocellular Carcinoma Showing Macrovascular Invasion
Frontiers in Oncology
Cancer Research
Oncology
Transcatheter Arterial Chemoembolization After Stopping Sorafenib Therapy for Advanced Hepatocellular Carcinoma
PLoS ONE
Multidisciplinary
Comparison of Microwave Ablation and Transcatheter Ablation and Transcatheter Arterial Chemoembolization in the Treatment of Early Hepatocellular Carcinoma
Ibnosina Journal of Medicine and Biomedical Sciences
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Retrospective Analysis of Transarterial Chemoembolization and Sorafenib in Chinese Patients With Unresectable and Recurrent Hepatocellular Carcinoma
Oncotarget
Oncology
Advanced Recurrent Hepatocellular Carcinoma: Treatment With Sorafenib Alone or in Combination With Transarterial Chemoembolization and Radiofrequency Ablation
Radiology
Nuclear Medicine
Radiology
Imaging
Prognostic Value of Serum Γ‑glutamyl Transferase in Unresectable Hepatocellular Carcinoma Patients Treated With Transcatheter Arterial Chemoembolization Combined With Conformal Radiotherapy
Oncology Letters
Cancer Research
Oncology
